Accelerate Diagnostics Inc (AXDX)
1.64
-0.03
(-1.80%)
USD |
NASDAQ |
Nov 22, 16:00
1.65
+0.01
(+0.61%)
After-Hours: 20:00
Accelerate Diagnostics Enterprise Value: 78.16M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 78.16M |
| November 21, 2024 | 78.92M |
| November 20, 2024 | 79.67M |
| November 19, 2024 | 80.92M |
| November 18, 2024 | 82.17M |
| November 15, 2024 | 83.42M |
| November 14, 2024 | 83.92M |
| November 13, 2024 | 84.43M |
| November 12, 2024 | 86.18M |
| November 11, 2024 | 84.93M |
| November 08, 2024 | 82.92M |
| November 07, 2024 | 86.43M |
| November 06, 2024 | 86.93M |
| November 05, 2024 | 87.56M |
| November 04, 2024 | 83.63M |
| November 01, 2024 | 85.12M |
| October 31, 2024 | 84.88M |
| October 30, 2024 | 83.88M |
| October 29, 2024 | 83.13M |
| October 28, 2024 | 83.88M |
| October 25, 2024 | 83.88M |
| October 24, 2024 | 81.14M |
| October 23, 2024 | 81.64M |
| October 22, 2024 | 83.38M |
| October 21, 2024 | 83.13M |
| Date | Value |
|---|---|
| October 18, 2024 | 82.14M |
| October 17, 2024 | 80.64M |
| October 16, 2024 | 84.38M |
| October 15, 2024 | 83.63M |
| October 14, 2024 | 79.90M |
| October 11, 2024 | 80.89M |
| October 10, 2024 | 82.88M |
| October 09, 2024 | 82.64M |
| October 08, 2024 | 84.88M |
| October 07, 2024 | 83.88M |
| October 04, 2024 | 85.62M |
| October 03, 2024 | 82.39M |
| October 02, 2024 | 82.88M |
| October 01, 2024 | 83.13M |
| September 30, 2024 | 79.65M |
| September 27, 2024 | 72.99M |
| September 26, 2024 | 71.57M |
| September 25, 2024 | 71.33M |
| September 24, 2024 | 67.55M |
| September 23, 2024 | 67.55M |
| September 20, 2024 | 67.78M |
| September 19, 2024 | 66.12M |
| September 18, 2024 | 66.12M |
| September 17, 2024 | 66.36M |
| September 16, 2024 | 67.31M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
38.69M
Minimum
Apr 17 2024
1.066B
Maximum
Jul 16 2020
330.83M
Average
176.74M
Median
Jul 18 2022
Enterprise Value Benchmarks
| Bruker Corp | 10.84B |
| Perspective Therapeutics Inc | -31.63M |
| Electromed Inc | 238.10M |
| Xtant Medical Holdings Inc | 83.10M |
| Senseonics Holdings Inc | 166.61M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.64M |
| Revenue (Quarterly) | 2.975M |
| Total Expenses (Quarterly) | 11.59M |
| EPS Diluted (Quarterly) | -0.59 |
| Gross Profit Margin (Quarterly) | 28.77% |
| Profit Margin (Quarterly) | -492.1% |
| Earnings Yield | -161.0% |
| Normalized Earnings Yield | -157.87 |